Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 7, 1996, Pages 533-539

  Dorgan, Joanne F ^a   Longcope, Christopher ^b   Stephenson Jr , Hugh E ^c   Falk, Roni T ^a   Miller, Rosetta ^c   Franz, Charlene ^b   Kahle, Lisa ^d   Campbell, William S ^a   Tangrea, Joseph A ^a   Schatzkin, Arthur ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE DISTRIBUTION; ANDROGENS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 15844363258     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kelsey, J. L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15: 256-263, 1993.
2. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pastemack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst., 87: 190-197, 1995.
3. Helzlsouer, K. J., Alberg, A. J., Bush, T. L., Longcope, C, Gordon, G. B., and Comstock, G. W. A prospective study of endogenous hormones and breast cancer. Cancer Detect. Prev., 18: 79-85, 1994.
4. Wysowski, D. K., Comstock, G. W., Helsing, K. J., and Lau, H. L. Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol., 125: 791-799, 1987.
5. Garland, C. F., Friedlander, N. J., Barrett-Connor, E., and Khaw, K. T. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol., 135: 1220-1230, 1992.
6. Moore, J. W., Clark, G. M. G., Hoare, S. A., Millis, R. R., Hayward, J. L., Quinlan, M. K., Wang, D. Y., and Bulbrook, R. D. Binding of oE2 to blood proteins and aetiology of breast cancer. Int. J. Cancer, 38: 625-630, 1986.
7. Thijssen, J. H. H., and Blankenstein, M. A. Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissue. Eur. J. Cancer Clin. Oncol., 25: 1953-1959, 1989.
8. Perel, E., Blackstein, M. E., and Killinger, D. W., Aromatase in human breast carcinoma. Cancer Res., 42(Suppl.): 3369s-3372s, 1982.
9. James, V. H. T., McNeill, J. M., Lai, L. C., Newton, C. J., Ghilchik, M. W., and Reed, M. J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids, 50: 269-279, 1987.
10. Lippman, M., Bolan, G., and Huff, K. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res., 36: 4610-4618, 1976.
11. Longcope, C., Franz, C., Morello, C., Baker, R., and Johnston, C. C. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas, 8: 189-196, 1986.
12. Longcope, C., Hui, S. L., and Johnston, C. C. Free E2, free testosterone and sex hormone binding globulin in peri-menopausal women. J. Clin. Endocrinol. Metab., 64: 513-518, 1987.
13. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research, Vol. 1. The Analysis of Case-Control Studies, pp. 248-279. Lyon, France: IARC, 1980.
14. SAS Institute, Inc. SAS User's Guide, Version 6. Cary, NC: SAS Institute, Inc., 1990.
15. USPHS. Cancer Statistics Review 1973-1986, p. III.30. Washington DC: United States Department of Health and Human Services, 1989.
16. O'Malley, B. W., and Strott, C. A. Steroid hormones: metabolism and mechanism of action. In: S. S. C. Yen and R. B. Jaffey (eds.), Reproductive Endocrinology, Ed. 3, pp. 156-180. Philadelphia: W. B. Saunders Co., 1991.
17. Vermeulen, A., Deslypere, J. P., Paridaens, R., Leclercq, G., Roy, F., and Heuson, J. C. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol., 22: 515-525, 1986.
18. Iqbal, M. J., Valyani, S. H., and Roberts, J. V. Mechanisms of sex-steroid accumulation in the aetiology of human breast carcinoma: the role of intracellular sex hormone binding globulin. Anticancer Res., 8: 479-482, 1988.
19. Van Landeghem, A. A. J., Poortman, J., Nabuurs, M., and Thijssen, J. H. H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res., 45: 2900-2906, 1985.
20. Thijssen, J. H. H., Blankenstein, M. A., Donker, G. H., and Daroszewski, J. Endogenous steroid hormones and local aromatase activity in the breast. J. Steroid Biochem. Mol. Biol., 39: 799-804, 1991.
21. O'Neill, J. S., and Miller, W. R. Aromatase activity in breast adipose tissue from women with benign and malignant diseases. Br. J. Cancer, 56: 601-604, 1987.
22. Adami, H. O., Johansson, E. D. B., Vegelius, J., and Victor, A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Upsala J. Med. Sci., 84: 259-274, 1979.
23. Secreto, G., Toniolo, P., Berrino, F., Recchione, C., Cavalleri, A., Pisani, P., Totis, A., Fariselli, G., and DiPietro, S. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res., 51: 2572-2576, 1991.
24. Secreto, G., Recchione, C., Cavalleri, A., Miraglia, M., and Dati, V. Circulating levels of testosterone, 17β-oE2, luteinizing hormone and prolactin in postmenopausal breast cancer patients. Br. J. Cancer, 47: 269-275, 1983.
25. McFadyen, I. J., Forrest, A. P. M., Prescott, R. J., Golder, M. P., Groom, G. V., Fahmy, D. R., and Griffiths, K. Circulating hormone concentrations in women with breast cancer. Lancet, 1: 1100-1102, 1976.
26. Hill, P., Garbaczewski, L., and Kasumi, F. Plasma testosterone and breast cancer. Eur. J. Cancer Clin. Oncol., 21: 1265-1266, 1985.
27. Hill, P., Garbaczewski, L., and Wynder, E. L. Testosterone in breast fluid. Lancet, 1: 761, 1983.
28. Sommer, S. C. Endocrine abnormalities in women with breast cancer. Lab. Invest., 4: 160-174, 1955.
29. Grattarolo, R. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am. J. Obstet. Gynecol., 116: 423-428, 1973.
30. Miller, W. R., McDonald, D., Forrest, A. P. M., and Shivas, A. A. Metabolism of androgens by human breast tissue. Lancet, 1: 912-913, 1973.
31. Varela, R. M., and Dao. T. L. Estrogen synthesis and E2 binding by human mammary tumors. Cancer Res., 38: 2429-2433, 1978.
32. Perel, E., Wilkins, D., and Killinger, D. W. The conversion of androstenedione to estrone, E2, and testosterone in breast tissue. J. Steroid Biochem., 13: 89-94, 1980.
33. Fan, C., Shu-shi, W., Qing-tai, D., Li-ying, X., Wan-ying, L., Wen-xiu, Y., and Zhen-guo, W. A study of plasma sex hormone levels in patients with breast cancer. Chin. Med. J., 98: 507-510, 1985.
34. Hamed, H., Caleffi, M., Fentiman, I. S., Thomas, B., and Bulbrook, R. D. Steroid hormones in lymph and blood from women with early breast cancer. Eur. J. Cancer, 27: 42-44, 1991.
35. Van Landeghem, A. A. J., Poortman, J., Deshpande, N., Di Martino, L., Tarquini, A., Thijssen, J. H. H., and Schwarz, F. Plasma concentration gradient of steroid hormones across human mammary tumors in vivo. J. Steroid Biochem., 14: 741-747, 1981.
36. Massobrio, M., Migliardi, M., Cassoni, P., Menzaghi, C., Revelli, A., and Cenderelli, G. Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer? J. Steroid Biochem. Mol. Biol., 51: 175-181, 1994.
37. Reed, M. J., Beranek, P. A., Ghilchik, M. W., and James, V. H. T. Conversion of estrone to E2 and E2 to estrone in postmenopausal women. Obstet. Gynecol., 66: 361-365, 1985.
38. Gordon, G. B., Shantz, L. M., and Talalay, P. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv. Enzyme Regul., 26: 355-382, 1987.
39. Gordon, G. B., Bush, T. L., Helzlsouer, K. J., Miller, S. R., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res., 50: 3859-3862, 1990.
40. Barrett-Connor, E., Friedlander, N. J., and Khaw, K. T. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res., 50: 6571-6574, 1990.